Merck (MRK) stock rises as Summit Therapeutics (SMMT) posts latest survival data for lung cancer therapy ivonescimab developed with Akeso
https://seekingalpha.com/news/4435941-merck-stock-gains-summit-data-cancer-drug
Merck (MRK) stock rises as Summit Therapeutics (SMMT) posts latest survival data for lung cancer therapy ivonescimab developed with Akeso
https://seekingalpha.com/news/4435941-merck-stock-gains-summit-data-cancer-drug
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.